SYNCOMF vs WANBURY: Stock Comparison

SYNCOM FORMU (I) vs WANBURYUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

SYNCOM FORMU (I) is the larger company by market capitalisation. SYNCOM FORMU (I) shows faster revenue growth, lower leverage and a higher net margin, while WANBURY shows a lower P/E, a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SYNCOMF leads 6; WANBURY leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SYNCOMFWANBURY

Valuation lens

What price are you paying?

Market CapContext only
₹1,833 Cr
₹832 Cr
P/E RatioWANBURY has the lower reading
21.24x
0x
P/B RatioWANBURY has the lower reading
4.38x
0x
EPSWANBURY has the higher reading
₹0.26
₹0.93
Book ValueContext only
₹4.41
₹41.34
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SYNCOMF is the larger company
₹1,833 Cr vs ₹832 Cr
P/E Ratio
WANBURY has a lower P/E
0x vs 21.24x
P/B Ratio
WANBURY has a lower P/B
0x vs 4.38x
EPS
WANBURY has higher earnings per share
₹0.93 vs ₹0.26
Revenue Growth (TTM YoY)
SYNCOMF has faster revenue growth
-9% vs -19.2%
EPS Growth (TTM YoY)
SYNCOMF has faster EPS growth
68.8% vs 0%
Qtr Sales Growth
WANBURY has stronger quarterly sales growth
0.61% vs -0.69%
Qtr Profit Growth
SYNCOMF has stronger quarterly profit growth
-1.04% vs -85.06%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSYNCOMFWANBURY
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricSYNCOMFWANBURY
Live Price₹19.46₹239.35
Day Change1.04%-0.87%
Volume91.48 L59,568
52-Week High₹22.59₹358.85
52-Week Low₹10.21₹161.5
Distance from 52W High-13.86%-33.3%

Valuation

MetricSYNCOMFWANBURY
Market Cap₹1,833 Cr₹832 Cr
P/E Ratio21.24x0x
P/B Ratio4.38x0x
EPS₹0.26₹0.93
Book Value₹4.41₹41.34
Dividend Yield0%0%

Growth

MetricSYNCOMFWANBURY
Revenue Growth (TTM YoY)-9%-19.2%
EPS Growth (TTM YoY)68.8%0%
Qtr Sales Growth-0.69%0.61%
Qtr Profit Growth-1.04%-85.06%

Profitability & Leverage

MetricSYNCOMFWANBURY
ROE18.42%45.78%
ROCE18.57%25.06%
Net Margin15.63%10.17%
Operating Margin20.91%13.81%
Debt to Equity0x1.49x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSYNCOMFWANBURY
Promoter Holding50.57%34.36%
FII Holding0.35% 0.14 pp0.89% 0.3 pp
DII Holding0%0.06% 0.06 pp
Public Holding49.08% 0.13 pp56.03% 0.36 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SYNCOM FORMU (I) and WANBURY.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.